Herbas VPB

Print
EN | LT
LT - SGLT2 inhibitoriai, skirti šuninių gyvūnų medžiagų apykaitos sutrikimų gydymui
EN - SGLT2 INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS

Legal status

Patent revoked (after opposition at EPO)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/7034 (2006.01)
A61P 3/06 (2006.01)
A61P 3/10 (2006.01)
A61K 9/02 (2006.01)
A61K 9/08 (2006.01)
A61K 9/20 (2006.01)
A61K 9/48 (2006.01)
A61K 38/28 (2006.01)
A61K 45/06 (2006.01)
A61K 31/00 (2006.01)
A61P 1/16 (2006.01)
A61P 1/18 (2006.01)
A61P 13/12 (2006.01)
A61P 19/00 (2006.01)
A61P 21/00 (2006.01)
A61P 27/02 (2006.01)
A61P 27/12 (2006.01)
A61P 29/00 (2006.01)
A61P 3/00 (2006.01)
European patent
(11) Number of the document 3485890
(13) Kind of document T
(96) European patent application number 18208143.0
Date of filing the European patent application 2015-01-20
(97) Date of publication of the European application 2019-05-22
(45) Date of publication and mention of the grant of the patent 2023-05-10
(46) Date of publication of the claims translation 2023-07-25
Priority applications
(30) Number Date Country code
14152327 2014-01-23 EP
14186477 2014-09-25 EP
Inventors
(72)
REICHE, Dania Birte , DE
KLEY, Saskia , DE
Grantee
(73) Boehringer Ingelheim Vetmedica GmbH , Binger Strasse 173, 55216 Ingelheim am Rhein, DE
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) SGLT2 inhibitoriai, skirti šuninių gyvūnų medžiagų apykaitos sutrikimų gydymui
  SGLT2 INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS
Last renewal fee
Payment date Validity (years) Amount
2024-12-27 11 289.00 EUR
Legal status
Patent revoked (after opposition at EPO)
Invalidation date 2025-06-04